ESC 365 - Doctor Mia Ravn Jacobsen

Speaker illustration

Doctor Mia Ravn Jacobsen

Copenhagen (Denmark)

Implementation of prasugrel and prognostic outcomes after percutaneous coronary intervention for myocardial infarction: a nationwide observational study

Event: ESC Congress 2024

Topic: Antiplatelet Drugs

Session: Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention

Nationwide observational study of antithrombotic treatment strategies after coronary artery bypass graft surgery in patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Anticoagulants

Session: Oral anticoagulation in patients with atrial fibrillation

High bleeding risk in all-comers with ST-segment elevation myocardial infarction and use of P2Y12-inhibitiors

Event: ESC Congress 2022

Topic: Clinical

Session: Coronary artery disease

Efficacy and safety of clopidogrel, ticagrelor, and prasugrel in an all-comers population of patients with ST-segment elevation myocardial infarction

Event: ESC Congress 2020

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Evolving Management of ST-Segment Elevation Myocardial Infarction

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources